CLINICAL_TRIALS
trial_result
· 2024-08-14
Clinical Trial Update: Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) [Phase 3]
Summary
A Phase 3 trial of a marketed drug for menstrual migraine has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Organon and Co | Conditions: Migraine | Phase 3 | Status: COMPLETED